Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Interest in MicroRNA Research Driving Growth in Related Market Tools

By LabMedica International staff writers
Posted on 01 Jun 2012
A new study shows that an increased number of pharmaceutical and biotech companies are becoming interested in microRNA (miRNA) research due to advancements in molecular diagnostics and therapeutics. More...
As a result, a larger number of distribution companies are offering miRNA research tools and expanding the spectrum of their applications to cater to a wider range of life science areas.

In a recent study titled Analysis of MicroRNA Tools and Services Market in Europe, Frost & Sullivan (Palo Alto, CA, USA; www.frost.com), a global research and analysis company, examined various miRNA tools and services, including expression profiling and phenotypic screening, to determine that miRNA research is expanding across different fields.

The analysis found that miRNA research has become increasingly prominent in the cardiovascular, virology, endocrinology, plant science, and genetic disease fields. This has caused several other fields to develop an interest in auditing their gene expression analyses or epigenetic research by profiling miRNAs, explained Vinodh Jyotikumar, research consultant, Frost & Sullivan.

As new miRNAs and their functions are discovered, additional research fields may adopt an interest in the role of miRNAs in their disciplines, leading to the need for a wider variety of research tools.

A surge in miRNA research over the past four years has already led several life sciences vendors to offer miRNA research instruments. As competition intensifies, market participants will need to expand and differentiate their product options and capabilities to accommodate a broader range of interested fields.

"Service providers that do not offer in-house technologies must differentiate themselves by expanding tool options or adding capabilities," added Mr. Jyotikumar. "Companies may opt to provide multiple microarrays from various vendors, develop their own tools or offer specialized products, such as multiplex panels aimed at specific diseases."

Analysis of MicroRNA Tools and Services Market in Europe is part of the Frost & Sullivan Clinical Diagnostics Growth Partnership Services program.


Related Links:
Frost & Sullivan


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.